Related references
Note: Only part of the references are listed.Serum Endocan Levels Are Correlated with the Presence and Severity of Coronary Artery Disease in Patients with Hypertension
Xiang-sheng Wang et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2015)
Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: Comparative effects of amlodipine and valsartan
Turgay Celik et al.
BLOOD PRESSURE (2015)
Endocan is useful biomarker of survival and severity in sepsis
Dunja M. Mihajlovic et al.
MICROVASCULAR RESEARCH (2014)
Endocan as a potential diagnostic or prognostic biomarker for chronic kidney disease
Hyun Gyu Lee et al.
KIDNEY INTERNATIONAL (2014)
Biological and clinical implications of endocan in gastric cancer
Wenyan Zhao et al.
TUMOR BIOLOGY (2014)
Lower serum endocan levels are associated with the development of acute lung injury after major trauma
Mark E. Mikkelsen et al.
JOURNAL OF CRITICAL CARE (2012)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Adipose tissue and circulating endothelial cell specific molecule-1 in human obesity
J Janke et al.
HORMONE AND METABOLIC RESEARCH (2006)
Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1
D Béchard et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
